Bioactivation of xenobiotics by formation of toxic glutathione conjugates.
Evidence has been accumulating that several classes of compounds are converted by glutathione conjugate formation to toxic metabolites. The aim of this review is to summarize the current knowledge on the biosynthesis and toxicity of glutathione S-conjugates derived from halogenated alkanes, halogenated alkenes, and hydroquinones and quinones. Different types of toxic glutathione conjugates have been identified and will be discussed in detail: (i) conjugates which are transformed to electrophilic sulfur mustards, (ii) conjugates which are converted to toxic metabolites in an enzyme-catalyzed multistep mechanism, (iii) conjugates which serve as a transport form for toxic quinones and (iv) reversible glutathione conjugate formation and release of the toxic agent in cell types with lower glutathione concentrations. The kidney is the main, with some compounds the exclusive, target organ for compounds metabolized by pathways (i) to (iii). Selective toxicity to the kidney is easily explained due to the capability of the kidney to accumulate intermediates formed by processing of S-conjugates and to bioactivate these intermediates to toxic metabolites. The influences of other factors participating in the renal susceptibility are discussed.
Koob
M
M
Institut für Toxikologie, Universität Würzburg, F.R.G.
Dekant
W
W
D000473:Alkanes / Q000378:metabolism; D000475:Alkenes / Q000378:metabolism; D000818:Animals; D001711:Biotransformation; D005978:Glutathione / Q000378:metabolism*; D006846:Hydrocarbons, Halogenated / Q000378:metabolism; D006873:Hydroquinones / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D011809:Quinones / Q000378:metabolism; D015262:Xenobiotics / Q000378:metabolism*
D000473:Alkanes; D000475:Alkenes; D006846:Hydrocarbons, Halogenated; D006873:Hydroquinones; D011809:Quinones; D015262:Xenobiotics; D005978:Glutathione